Who owns SAGIMET BIOSCIENCES INC-A?
- Ticker: SGMT
- CUSIP Number: 786700104
Tip: Access positions for across all investors
Analyze quarterly positions in Sagimet Biosciences Inc-a with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sagimet Biosciences Inc-a stock
Who bought or sold SAGIMET BIOSCIENCES INC-A this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 3.9M | $19M | 0% | Dec 2023 |
|
| Baker Bros. Advisors | 1.5M | $7.9M | 79% | Dec 2023 |
|
| Hillhouse Capital Advisors | 1.4M | $7.9M | 0% | Dec 2023 |
|
| Artal Group | 925k | $5.0M | 0% | Dec 2023 |
|
| Partner Fund Management | 677k | $3.7M | 0% | Dec 2023 |
|
| Alyeska Investment Group | 487k | $2.6M | 103% | Dec 2023 |
|
| Blue Owl Capital Holdings | 355k | $1.9M | 100% | Dec 2023 |
|
| Vanguard Group | 245k | $1.3M | 0% | Dec 2023 |
|
| Dumac | 204k | $1.1M | 0% | Dec 2023 |
|
| AlphaCentric Advisors | 185k | $1.0M | 100% | Mar 2024 |
|
| Federated Investors | 97k | $527k | 25% | Dec 2023 |
|
| Bank of New York Mellon | 62k | $337k | 181% | Mar 2024 |
|
| Victory Capital Management | 57k | $307k | 215% | Dec 2023 |
|
| Millennium Management | 48k | $260k | 293% | Dec 2023 |
|
| Two Sigma Investments | 44k | $238k | 100% | Dec 2023 |
|
| DekaBank Deutsche Girozentrale | 20k | $113k | 100% | Mar 2024 |
|
| UBS Group | 20k | $108k | 568% | Dec 2023 |
|
| Marshall Wace | 17k | $91k | 100% | Dec 2023 |
|
| Bank of America Corporation | 17k | $90k | 28% | Dec 2023 |
|
| Charles Schwab Investment Management | 13k | $68k | 0% | Dec 2023 |
|
| Virtu Financial | 12k | $67k | 100% | Dec 2023 |
|
| Barclays | 7.6k | $41k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 6.4k | $34k | 0% | Dec 2023 |
|
| Sandia Investment Management | 6.0k | $32k | -40% | Dec 2023 |
|
| Rhumbline Advisers | 5.3k | $29k | -3% | Dec 2023 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 4.5k | $24k | 309% | Dec 2023 |
|
| Jpmorgan Chase & Co | 3.5k | $19k | 0% | Dec 2023 |
|
| American International | 2.8k | $15k | 3% | Dec 2023 |
|
| Royal Bank of Canada | 1.7k | $11k | 91% | Dec 2023 |
|
| Wells Fargo & Company | 1.6k | $8.6k | 31% | Dec 2023 |
|
| Newbridge Financial Services Group | 1.5k | $8.1k | 0% | Mar 2024 |
|
| Citigroup | 858.00 | $4.7k | 100% | Dec 2023 |
|
| Summit Investment Advisors | 525.00 | $2.8k | 0% | Dec 2023 |
|
| Legal & General Group | 487.00 | $2.6k | 0% | Dec 2023 |
|
| Amalgamated Bank | 185.00 | $999.999000 | -65% | Mar 2024 |
|
| Toth Financial Advisory Corporation | 90.00 | $487.998000 | 100% | Mar 2024 |
|
Who sold out of Sagimet Biosciences Inc-a?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| VR Adviser | Sep 2023 | 515k | $4.5M |
| Citadel Advisors | Sep 2023 | 312k | $2.7M |
| Squarepoint Ops | Sep 2023 | 35k | $308k |
| Teacher Retirement System Of Texas | Sep 2023 | 25k | $220k |
| Goldman Sachs Group | Sep 2023 | 20k | $173k |